SLC5A2 and Ventricular arrhythmia: The interaction of SGLT2 inhibitors with ion-handling system can be of relevance, because a reduced risk of ventricular arrhythmias and sudden cardiac deaths (signs of a modulation of ion-handling system) was detected in CV safety trials.